BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28329304)

  • 1. Cystic Fibrosis Pulmonary Exacerbations Attributable to Respiratory Syncytial Virus and Influenza: A Population-Based Study.
    Somayaji R; Goss CH; Khan U; Neradilek M; Neuzil KM; Ortiz JR
    Clin Infect Dis; 2017 Jun; 64(12):1760-1767. PubMed ID: 28329304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza-associated cystic fibrosis pulmonary exacerbations.
    Ortiz JR; Neuzil KM; Victor JC; Wald A; Aitken ML; Goss CH
    Chest; 2010 Apr; 137(4):852-60. PubMed ID: 19965953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palivizumab immunoprophylaxis effectiveness in children with cystic fibrosis.
    Winterstein AG; Eworuke E; Xu D; Schuler P
    Pediatr Pulmonol; 2013 Sep; 48(9):874-84. PubMed ID: 23139089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Human Immunodeficiency Virus in Influenza- and Respiratory Syncytial Virus-associated Hospitalizations in South African Children, 2011-2016.
    McMorrow ML; Tempia S; Walaza S; Treurnicht FK; Moyes J; Cohen AL; Pretorius M; Hellferscee O; Wolter N; von Gottberg A; Nguweneza A; McAnerney JM; Naby F; Mekgoe O; Venter M; Madhi SA; Cohen C
    Clin Infect Dis; 2019 Feb; 68(5):773-780. PubMed ID: 29961814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and clinical impact of respiratory viruses in adults with cystic fibrosis.
    Flight WG; Bright-Thomas RJ; Tilston P; Mutton KJ; Guiver M; Morris J; Webb AK; Jones AM
    Thorax; 2014 Mar; 69(3):247-53. PubMed ID: 24127019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary exacerbations and clinical outcomes in a longitudinal cohort of infants and preschool children with cystic fibrosis.
    Hoppe JE; Wagner BD; Sagel SD; Accurso FJ; Zemanick ET
    BMC Pulm Med; 2017 Dec; 17(1):188. PubMed ID: 29228933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral respiratory tract infections in young children with cystic fibrosis: a prospective full-year seasonal study.
    Eymery M; Morfin F; Doleans-Jordheim A; Perceval M; Ohlmann C; Mainguy C; Reix P
    Virol J; 2019 Sep; 16(1):111. PubMed ID: 31481063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic Corticosteroids in the Management of Pediatric Cystic Fibrosis Pulmonary Exacerbations.
    Davis CS; Faino AV; Onchiri F; Gibson RL; Merjaneh L; Ramsey BW; Rosenfeld M; Cogen JD
    Ann Am Thorac Soc; 2023 Jan; 20(1):75-82. PubMed ID: 36044723
    [No Abstract]   [Full Text] [Related]  

  • 9. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008.
    Zhou H; Thompson WW; Viboud CG; Ringholz CM; Cheng PY; Steiner C; Abedi GR; Anderson LJ; Brammer L; Shay DK
    Clin Infect Dis; 2012 May; 54(10):1427-36. PubMed ID: 22495079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic Regimen Changes during Cystic Fibrosis Pediatric Pulmonary Exacerbation Treatment.
    Cogen JD; Sanders DB; Slaven JE; Faino AV; Somayaji R; Gibson RL; Hoffman LR; Ren CL
    Ann Am Thorac Soc; 2023 Sep; 20(9):1293-1298. PubMed ID: 37327485
    [No Abstract]   [Full Text] [Related]  

  • 11. Hospitalizations associated with influenza and respiratory syncytial virus among patients attending a network of private hospitals in South Africa, 2007-2012.
    Kyeyagalire R; Tempia S; Cohen AL; Smith AD; McAnerney JM; Dermaux-Msimang V; Cohen C
    BMC Infect Dis; 2014 Dec; 14():694. PubMed ID: 25510622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimates of hospitalization attributable to influenza and RSV in the US during 1997-2009, by age and risk status.
    Matias G; Taylor R; Haguinet F; Schuck-Paim C; Lustig R; Shinde V
    BMC Public Health; 2017 Mar; 17(1):271. PubMed ID: 28320361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating influenza and respiratory syncytial virus-associated mortality in Western Kenya using health and demographic surveillance system data, 2007-2013.
    Emukule GO; Spreeuwenberg P; Chaves SS; Mott JA; Tempia S; Bigogo G; Nyawanda B; Nyaguara A; Widdowson MA; van der Velden K; Paget JW
    PLoS One; 2017; 12(7):e0180890. PubMed ID: 28686692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human metapneumovirus and respiratory syncytial virus infections in older children with cystic fibrosis.
    Garcia DF; Hiatt PW; Jewell A; Schoonover SL; Cron SG; Riggs M; Grace S; Oermann CM; Piedra PA
    Pediatr Pulmonol; 2007 Jan; 42(1):66-74. PubMed ID: 17123316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The burden of influenza and RSV among inpatients and outpatients in rural western Kenya, 2009-2012.
    Emukule GO; Khagayi S; McMorrow ML; Ochola R; Otieno N; Widdowson MA; Ochieng M; Feikin DR; Katz MA; Mott JA
    PLoS One; 2014; 9(8):e105543. PubMed ID: 25133576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of respiratory syncytial virus infection and influenza with emergency admissions for respiratory disease in London: an analysis of routine surveillance data.
    Mangtani P; Hajat S; Kovats S; Wilkinson P; Armstrong B
    Clin Infect Dis; 2006 Mar; 42(5):640-6. PubMed ID: 16447109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and long-term outcomes of palivizumab prophylaxis to prevent respiratory syncytial virus infection in infants with cystic fibrosis in Northern Ireland.
    Groves HE; Jenkins L; Macfarlane M; Reid A; Lynn F; Shields MD
    Pediatr Pulmonol; 2016 Apr; 51(4):379-85. PubMed ID: 26808981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children.
    Iwane MK; Edwards KM; Szilagyi PG; Walker FJ; Griffin MR; Weinberg GA; Coulen C; Poehling KA; Shone LP; Balter S; Hall CB; Erdman DD; Wooten K; Schwartz B;
    Pediatrics; 2004 Jun; 113(6):1758-64. PubMed ID: 15173503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory Syncytial Virus Infection-associated Hospitalization Rates in Infants and Children With Cystic Fibrosis.
    Metz J; Eber E; Resch B
    Pediatr Infect Dis J; 2017 Jun; 36(6):545-548. PubMed ID: 28005688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory syncytial virus prophylaxis in cystic fibrosis: the Canadian registry of palivizumab data (2005-2016).
    Mitchell I; Wong SK; Paes B; Ruff M; Bjornson C; Li A; Lanctôt KL;
    Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1345-1352. PubMed ID: 29728782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.